SCHEMBL5888026

SCHEMBL5888026

COCCOCOc1ccc(/C(C)=C/c2ccc(Br)nc2)cc1C12CC3CC(CC(C3)C1)C2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARA P10276 7/20 0.59
IKBKB O14920 4/20 0.59
RARG P13631 8/20 0.52
RARB P10826 5/20 0.52
HDAC11 Q96DB2 3/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
MEN1 O00255 1/20 0.33
NR1I2 O75469 1/20 0.33
LMNA P02545 1/20 0.33
PGR P06401 1/20 0.33
HSPD1 P10809 1/20 0.33
GOT1 P17174 1/20 0.33
GLRA1 P23415 1/20 0.33
BLM P54132 1/20 0.33
HSPE1 P61604 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888199 0.87 RARA (0.63) RARAIKBKBRARGRARBHDAC11
SCHEMBL5887816 0.87 RARA (0.66) RARAIKBKBRARGRARBHDAC11
SCHEMBL7757436 0.87 RARA (0.66) RARAIKBKBRARGRARBHDAC11
SCHEMBL5888246 0.87 RARA (0.66) RARAIKBKBRARGRARBHDAC11
SCHEMBL5888184 0.86 RARA (0.62) RARAIKBKBRARGRARBHDAC11
SCHEMBL5888169 0.86 RARA (0.64) RARAIKBKBRARGRARBHDAC11
SCHEMBL5887935 0.86 RARA (0.60) RARAIKBKBRARGRARBHDAC11
SCHEMBL5887942 0.86 RARA (0.60) RARAIKBKBRARGRARBHDAC11
SCHEMBL7756392 0.86 RARA (0.62) RARAIKBKBRARGRARBHDAC11
SCHEMBL7756350 0.86 RARA (0.62) RARAIKBKBRARGRARBHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6992095-B2 Stilbene compounds comprising an adamantyl group, compositions and methods thereof GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2006-01-31 US disclosed
US-20040067971-A1 Stilbene compounds comprising an adamantyl group, compositions and methods thereof GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2004-04-08 US disclosed
US-20020010337-A1 Stilbene compounds comprising an adamantyl group, compositions and methods thereof BERNARDON JEAN-MICHEL (FR) 2002-01-24 US disclosed
US-6214878-B1 SKIN DISORDERS; RHEUMATIC DISEASES; RESPIRATORY SYSTEM DISORDERS; CARDIOVASCULAR DISORDERS; VISION DEFECTS GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) 2001-04-10 US disclosed
EP-0850909-B1 Stilbene compounds with adamantyl group, compositions containing the same and uses CT INTERNAT DE (FR) 2001-03-21 EP disclosed
EP-0850909-A1 Stilbene compounds with adamantyl group, compositions containing the same and uses CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1998-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067971-A1 Stilbene compounds comprising an adamantyl group, compositions and methods thereof SQLE, FDFT1, PIGS RARA 1151/4885IKBKB 485/4885RARG 1564/4885
US-20020010337-A1 Stilbene compounds comprising an adamantyl group, compositions and methods thereof SQLE, FDFT1, PIGS RARA 1151/4885IKBKB 485/4885RARG 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.